Showing results (631-640 of 2,688) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|February 19, 2026
The looming crisis of bedaquiline-resistant tuberculosis and a promising way forwardPauline Howell, Jonathan Stillo, Anja Reuter, et al.
The Lancet. Infectious Diseases|November 10, 2024
A series of patients infected with the emerging tick-borne Yezo virus in China: an active surveillance and genomic analysisMing-Zhu Zhang, Cai Bian, Run-Ze Ye, et al.
The Lancet. Infectious Diseases|October 18, 2024
Re-emergence of Oropouche virus between 2023 and 2024 in Brazil: an observational epidemiological studyGabriel C Scachetti, Julia Forato, Ingra M Claro, et al.
The Lancet. Infectious Diseases|October 17, 2024
Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4/5, and XBB dominance in Hong Kong: a prospective cohort studyYawei Wang, Hau Chi So, Nicole Ngai Yung Tsang, et al.
The Lancet. Infectious Diseases|January 14, 2021
Routine universal testing versus selective or incidental testing for oropharyngeal Neisseria gonorrhoeae in women in the Netherlands: a retrospective cohort studyGeneviève A F S van Liere, Nicole H T M Dukers-Muijrers, Sophie Kuizenga-Wessel, et al.
The Lancet. Infectious Diseases|May 13, 2026
Post-mortem characterisation of pathogen-specific causes of infection-related deaths in African and south Asian neonates: a prospective, observational, multicentre studyMuntasir Alam, Kyu Han Lee, Vicky Baillie, et al.
The Lancet. Infectious Diseases|May 14, 2026
Understanding and exploiting superspreading to disrupt Mycobacterium tuberculosis transmissionTyler S Brown, Kristin Nelson, Stephen Kissler, et al.
The Lancet. Infectious Diseases|March 13, 2026
Post-discharge sequelae of Lassa fever survivors in Nigeria: an analysis of the LASCOPE prospective cohortEva Guichard, Sylvain Juchet, Ijeoma Chukwudumebi Etafo, et al.
The Lancet. Infectious Diseases|March 12, 2026
A combined ELISA for infection-induced and vaccine-induced mpox antibodies during the clade Ib outbreak in Rwanda: an observational, cross-sectional, clinical validation studyJenny Clarke, Herve Semukunzi, Sian E Faustini, et al.
The Lancet. Infectious Diseases|June 11, 2026
Yellow fever vaccination in healthy Gambian children of different ages to establish safety and immunogenicity of a booster dose: a open-label, non-randomised, single-site, phase 3 vaccine trialCaitlin Pley, David J Jeffries, Ebrima Kanteh, et al.
Pageof 269